MEREO BIOPHARMA

mereo-biopharma-logo

Mereo is based in London and was founded in March 2015 to fund and develop novel, innovative specialist focused products from large pharmaceutical or biotechnology companies. Pharmaceutical companies face increasingly difficult choices in the allocation of internal resources to their drug development programs. With significant P&L constraints and rich pipelines it has become increasingly difficult for many companies to fully fund and advance development all of their drug candidates, especi... ally beyond Phase 2. Mereo has been formed to take advantage of the global pharmaceutical industry's drive for creative ways to progress their clinical development pipelines. Mereo has acquired an initial mid-late stage portfolio of three exceptionally well characterised novel products for the treatment of diseases with considerable unmet medical need from Novartis Pharmaceuticals. Each of these programmes has a comprehensive dataset for both pre-clinical and proof-of-concept clinical studies. Additional product opportunities are under evaluation. Mereo's focus is the development of innovative medicines that have the potential to significantly transform the lives of patients suffering from rare and other specialised conditions around the world. To do this, the Company depends on the combination of its team's expertise in selecting and acquiring product opportunities, creating value in the development pipeline and structuring creative transactions. Mereo's internal expertise is complemented by a unique partnership with a leading global CRO, ICON. Mereo combines the operational discipline and efficiency of a small company with the financial resources to conduct comprehensive clinical studies. Mereo will rapidly progress each of the products through further value inflection points before partnering or divesting its products. The Company also has the option to directly commercialise products, for example in orphan disease indications.

#SimilarOrganizations #People #Financial #Event #Website #More

MEREO BIOPHARMA

Social Links:

Industry:
Biopharma Biotechnology Health Care Innovation Management

Founded:
2015-03-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.mereobiopharma.com

Total Employee:
11+

Status:
Active

Contact:
+4403330237300

Total Funding:
337.46 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Domain Not Resolving Mobile Non Scaleable Content Amazon


Similar Organizations

oncoquest-logo

OncoQuest

OncoQuest is a Edmonton-based biopharmaceutical company.

touchlight-genetics-logo

Touchlight Genetics

Touchlight Genetics, a British bio-pharmaceutical company founded in 2007.


Current Advisors List

jeremy-bender_image

Jeremy Bender Independent Board Member @ Mereo Biopharma
Board_member
2020-10-01

Current Employees Featured

alastair-mackinnon_image

Alastair MacKinnon
Alastair MacKinnon CMO and Co-Founder @ Mereo Biopharma
CMO and Co-Founder
2015-06-01

john-lewicki_image

John Lewicki
John Lewicki Chief Scientific Officer @ Mereo Biopharma
Chief Scientific Officer
2020-07-01

denise-scots-knight_image

Denise Scots-Knight
Denise Scots-Knight CEO and Co-Founder @ Mereo Biopharma
CEO and Co-Founder
2015-07-01

john-richard_image

John Richard
John Richard Head of Corporate Development & Co-Founder @ Mereo Biopharma
Head of Corporate Development & Co-Founder
2015-07-01

richard-bungay_image

Richard Bungay
Richard Bungay CFO/COO @ Mereo Biopharma
CFO/COO

wills-wilson_image

Wills Wilson
Wills Wilson Head of Patient Access & Commercial Planning @ Mereo Biopharma
Head of Patient Access & Commercial Planning
2018-03-01

charles-sermon_image

Charles Sermon
Charles Sermon General Counsel & Co-Founder @ Mereo Biopharma
General Counsel & Co-Founder
2015-07-01

ann-kapoun_image

Ann Kapoun
Ann Kapoun Senior Vice President, Translational Research & Development @ Mereo Biopharma
Senior Vice President, Translational Research & Development
2020-08-01

Founder


denise-scots-knight_image

Denise Scots-Knight

Stock Details


Company's stock symbol is LSE:MPH

Investors List

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - Mereo Biopharma

samsara-biocapital_image

Samsara BioCapital

Samsara BioCapital investment in Post-IPO Equity - Mereo Biopharma

commodore-capital_image

Commodore Capital

Commodore Capital investment in Post-IPO Equity - Mereo Biopharma

pontifax_image

Pontifax

Pontifax investment in Post-IPO Equity - Mereo Biopharma

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Post-IPO Equity - Mereo Biopharma

aspire-capital-fund_image

Aspire Capital Partners LLC

Aspire Capital Partners LLC investment in Post-IPO Equity - Mereo Biopharma

tavistock-group_image

Tavistock Group

Tavistock Group investment in Post-IPO Equity - Mereo Biopharma

vivo-capital_image

Vivo Capital

Vivo Capital investment in Post-IPO Equity - Mereo Biopharma

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Post-IPO Equity - Mereo Biopharma

boxer-capital_image

Boxer Capital

Boxer Capital investment in Post-IPO Equity - Mereo Biopharma

Key Employee Changes

Date New article
2020-06-30 Mereo BioPharma Appoints John Lewicki Chief Scientific Officer

Official Site Inspections

http://www.mereobiopharma.com Semrush global rank: 2.51 M Semrush visits lastest month: 7.01 K

  • Host name: 104.26.13.156
  • IP address: 104.26.13.156
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Mereo Biopharma"

Home | Mereo BioPharma

We are committed to helping patients with rare diseases. We identify and develop therapies with the greatest unrealized, long-term potential.See details»

Who we are - Mereo BioPharma

Mereo BioPharma (Mereo) was founded in March 2015 to fund and develop high-potential novel therapies that were not being progressed in pharmaceutical or biotechnology companies. We acquired a portfolio of three product candidates โ€ฆSee details»

Mereo BioPharma - LinkedIn

Welcome to Mereo BioPharma, we are an agile biopharmaceutical company, focused on finding and bringing to market therapies that will improve the lives of people living with a rare disease. We...See details»

Our Pipeline - Mereo BioPharma

At Mereo, we unlock the potential of rare disease therapies that were not being progressed in pharmaceutical or biotechnology companies โ€“ creating new possibilities for all our stakeholders, from our investors to the patients that โ€ฆSee details»

Mereo BioPharma - LinkedIn

Welcome to Mereo BioPharma, we are an agile biopharmaceutical company, focused on finding and bringing to market therapies that will improve the lives of people living with a rare disease. โ€ฆSee details»

Mereo BioPharma Reports on Recent Program Developments and โ€ฆ

LONDON, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (โ€œMereoโ€ or the โ€œCompanyโ€), a clinical-stage biopharmaceutical company focused on โ€ฆSee details»

Mereo Biopharma - Crunchbase Company Profile

Mereo is a new UK-based speciality biopharmaceutical company. Mereo Biopharma may be growing as indicated by several financial activities and corporate developments. The company has announced its full year 2023 โ€ฆSee details»

Company Description - Stock Analysis

Nov 18, 2024ย ยท Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United โ€ฆSee details»

Mereo BioPharma Group - Overview, News & Similar companies

May 21, 2024ย ยท View Mereo BioPharma Group (www.mereobiopharma.com) location in Greater London, United Kingdom , revenue, industry and description. Find related and similar โ€ฆSee details»

Mereo Biopharma - PitchBook

Developer of drugs and therapies catering to patients with rare diseases and cancer. The company is engaged in the development and commercialization of innovative therapeutics that โ€ฆSee details»

Investors - Results, Reports & Presentations | Mereo BioPharma

Mereo BioPharma Reports Full Year 2020 Financial Results and Recent Highlights. 31 March 2021See details»

Mereo BioPharma - Craft

Dec 17, 2020ย ยท See insights on Mereo BioPharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Mereo BioPharma Information - RocketReach

Mereo BioPharma is a Biotechnology Research, Drug Manufacturing & Research, and Biopharma company located in UK with $44.7 million in revenue and 46 employees. Find top employees, โ€ฆSee details»

Mereo BioPharma Group Ltd - VentureRadar

Website: http://www.mereobiopharma.com/ Develops therapies for rare diseases, particularly Osteogenesis Imperfecta, by collaborating with partners, patient communities, and healthcare โ€ฆSee details»

Mereo BioPharma Company Overview, Contact Details

Jun 14, 2024ย ยท Mereo BioPharma 's official website is mereobiopharma.com and has social profiles on LinkedIn. How much revenue does Mereo BioPharma generate? As of July 2024 , โ€ฆSee details»

Mereo BioPharma Group plc (MREO) - Yahoo Finance

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the โ€ฆSee details»

News - Mereo BioPharma

London, November 12, 2024 - Mereo BioPharma Group plc (NASDAQ: MREO) (โ€œMereoโ€ or the โ€œCompanyโ€), a clinical-stage biopharmaceutical company focused on rare diseases, today โ€ฆSee details»

Mereo BioPharma Announces Completion of $70 Million Private

Jun 4, 2020ย ยท LONDON and REDWOOD CITY, Calif., June 04, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH) today announces the completion โ€ฆSee details»

Mereo BioPharma Provides Update on Pipeline Progress and โ€ฆ

LONDON, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (โ€œMereoโ€ or the โ€œCompanyโ€), a clinical-stage biopharmaceutical company focused on โ€ฆSee details»

Mereo BioPharma Group plc (MREO) - Yahoo Finance Canada

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the โ€ฆSee details»

linkstock.net © 2022. All rights reserved